Navigation Links
Oak Ridge to lead auto supplier R&D partnership
Date:1/17/2008

he areas on which USAutoPARTs will initially focus are aligned with the Vehicle Technologies Program of DOEs Office of Energy Efficiency and Renewable Energy. Similar support is planned by the U.S. Department of Defense and anticipated from other Federal Agencies as the partnership develops.

Coming on the heels of the President signing new energy legislation last month, this alliance with state government and industry demonstrates a shared commitment to advance highly efficient vehicle technologies that will help reduce our reliance on foreign energy and promote robust economic growth, DOE Under Secretary Albright said. Furthering the Administrations comprehensive effort to increase energy security, we are eager for this alliance to take shape so cleaner, more efficient vehicles can successfully move from the laboratory to the showroom.

Oak Ridge National Laboratory is the leading national laboratory for the Vehicle Technologies Program of DOEs Office of Energy Efficiency and Renewable Energy and is home to the National Transportation Research Center as well as the High Temperature Materials Laboratory and other research facilities where researchers address issues of energy efficiency, air quality and dependence on foreign oil through innovations in engine control strategies, advanced emissions control and measurement, materials, fuels, power electronics, and electric machines.

ORNL is uniquely suited to addressing the needs of American automotive suppliers, said Thom Mason, director of Oak Ridge National Laboratory. We have a broad portfolio of transportation research and expertise in all aspects of the business, from lightweight components made of carbon fiber to electric motors. This partnership will support DOEs mission and help insure Americas future in the automotive business.

USAutoPARTs will be located in Shelby Township, Mich., in a 56,000 square foot vehicle R&D center with established laboratory infrastructure that
'/>"/>

Contact: Larisa Brass
brasslm@ornl.gov
865-574-4163
DOE/Oak Ridge National Laboratory
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Truck-safe bamboo bridge opens in China
2. Story tips from the Department of Energys Oak Ridge National Laboratory, December 2007
3. Story tips from the Department of Energys Oak Ridge National Laboratory, October 2007
4. Story tips from the US Department of Energys Oak Ridge National Laboratory, September 2007
5. New partnership offers outsourced R&D in membrane biology
6. GM, Coskata partnership builds on Oklahoma State University biofuels research
7. MIT, Eni announce energy research partnership
8. United Water, in partnership with Stevens, wins Management Innovation Award
9. Emory, Ohio State launch partnership in predictive and personalized health care
10. Elsevier announces new journal partnership for 2008
11. UD hosts conference on knowledge-based partnerships Nov. 2
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 2Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 3New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 2New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease 2Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease 3